Clinical efficacy of bronchial thermoplasty for severe bronchial asthma

Clinical efficacy of bronchial thermoplasty for severe bronchial asthma - Clinical efficacy of bronchial thermoplasty for severe bronchial asthma

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000044207

Enrollment

Registered

2021-05-14

Start date

2017-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bronchial asthma

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who completed bronchial thermoplasty at the Department of Respiratory Medicine, Osaka Red Cross Hospital between September 1, 2017 and October 31, 2019, and are continuously attending the outpatient clinic as of October 31, 2020.

Exclusion criteria

Exclusion criteria: Patients who failed to complete bronchial thermoplasty or discontinued hospital visits within one year of the procedure.

Design outcomes

Primary

Measure	Time frame
Change in AQLQ score from baseline survey to 3, 6, and 12 months after bronchial thermoplasty.	—

Secondary

Measure	Time frame
Change in %FEV1 and severe exacerbations from baseline survey to 3, 6, and 12 months after bronchial thermoplasty.	—

Countries

Japan

Contacts

Public ContactKyohei Morita

Osaka Red Cross Hospital Department of respiratory medicine

kyoheim0423@gmail.com0667745111

Outcome results